DOCSLIB.ORG

MAP: Mammography Advantage Pathway Resource

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MAP: Mammography Advantage Pathway Resource R E S ammography O U M R C E dvantage K A I T J © athway u n P e 2 HANYS BREAST CANCER DEMONSTRATION PROJECT™ 0 Healthcare Association of New York State One Empire Drive, Rensselaer, NY 12144 0 (518) 431-7600 ✦ www.hanys.org 3 TABLE OF CONTENTS The MAP: Mammography Advantage Pathway Resource Kit© ofTable Contents consists of the following components, which also are available online at www.hanys.org/quality_index/Breast_Cancer_Project/resourcekits.htm. Preface Statement by Rhonda Mealor, Principal, Oncology Solutions, LLC. Introduction: What Can This Kit Do For You? Provides an overview of the Resource Kit. HANYS BCDP Advisory Board Members Additional Resource Kits Available: Breast Health Patient Navigator Program Resource Kit© and Provider Tools for Bridging the Gap: A Resource Kit for Helping Newly Diagnosed Breast Cancer Patients© Thumbnail sketches and a Web link to two other resource kits developed by the HANYS BCDP™. MAP Self-Assessment Tool Self-administered data collection instrument specific to financial, clinical, and service areas of mammography care. Coding Resource Tools Samples you may wish to adapt to your organization. ■ Common Breast Cancer Screening, Detection, and Treatment Coding Guidelines ■ CPT Utilization Description and Update ● Attachment A ■ Technical Fee Schedule Comparison ■ Sample Professional and Technical Breast Imaging and Procedures Encounter Form ■ Sample Professional Breast Imaging and Procedures Encounter Form ■ Sample Technical Breast Imaging and Procedures Encounter Form Financial Resource Tools Samples you may wish to adapt for your organization: ■ Sample Pre-Registration Checklist ■ Sample Financial Management Reports ● Productivity Summary by Month ● Radiologist Productivity Summary ● Radiologist Productivity by User continued... Breast Imaging Information Systems Vendor Comparisons Compares automated clinical information system capabilities. Mammography Equipment Resource Tools Compares mammography equipment and film capabilities. ■ Mammography Equipment Vendor Comparisons ■ Mammography Film Vendor Comparisons Patient Satisfaction Survey Resource Tools Evaluate patients’ perception of care. ■ Sample Patient Satisfaction Survey Forms: ● Breast Health Program Patient Satisfaction Survey ● Center for Women’s Health Satisfaction Survey ● Health Care Giver Report Card Patient Education Survey Resource Tool Evaluate patients’ perception of the benefit of health care information they receive. ■ Sample Patient Education Survey Physician Satisfaction Survey Resource Tool Evaluate physicians’ level of satisfaction with breast health services. ■ Sample Physician Satisfaction Survey MAP Flow Charts Graphical presentations of performance improvement processes, mammography process overview, and possible action items. ■ Performance Improvement Process Template—Financial/Service/Clinical Sample Templates: ● Financial ● Clinical ● Service ■ Theoretical Flow Charts ● Screening Mammography to Definitive Diagnosis: Theoretical Flow Chart and Process ● Screening Mammography: Theoretical Flow Chart and Process ● Diagnostic Mammography: Theoretical Flow Chart and Process ● Biopsy to Definitive Diagnosis: Theoretical Flow Chart and Process Using the MAP: Mammography Advantage Pathway Resource Kit© Microsoft® PowerPoint presentation to help you present the information contained in this book. Rationale and Supporting Research Resources and support for best practice process framework in mammography care. ■ Appendix A–Breast Imaging Reporting and Data System (BI-RADS®) Reporting Categories PREFACE Rhonda Mealor, Principal, Oncology Solutions, LLC Preface New York State boasts many favorable distinctions. Having the second highest incidence of breast cancer in the nation is not one of them. New technologies and techniques in breast cancer diagnosis and treatment have improved the prognosis for women with image-detected cancers.1 Yet, breast cancer continues to be the sec- ond leading cause of death in women. While this tragedy continues, the reimbursement for diagnostic breast services continues to decline and the struggle to manage the enormous respon- sibilities of a breast center becomes increasingly difficult. However, with sound knowledge, incisive thinking, and perseverance, hospitals, physicians, and health care professionals can work collaboratively to positively affect the screening, detection, and diagnosis process for individuals in their communities. The MAP: Mammography Advantage Pathway Resource Kit, developed by the Healthcare Association of New York State Breast Cancer Demonstration ProjectTM in conjunction with Oncology Solutions, LLC, can help. Facility Self-Assessment The MAP: Mammography Advantage Pathway Resource Kit© and the MAP Self-Assessment Tool were developed after extensive work, including wide-ranging surveys and on-site interviews, with four very generous demonstration hospitals. The MAP Self-Assessment Tool helps health care teams to: ■ perform a self-assessment of mammography services from the point of screening to the point of definitive diagnosis; ■ measure levels of financial, clinical, and service efficiencies for mammography services; ■ identify areas for improvement; ■ stimulate an internal review regarding current processes in breast care; and ■ open dialogue among staff within and between departments. This Resource Kit is designed to ensure that any change hospitals incorporate will lead toward a more standard approach to service, clinical, and financial processes. It provides the background and resource data needed to base changes on a solid foundation of information. Three indica- tors—service, clinical, and financial—were used in the development of this Resource Kit. Because many of the indicators are not “black and white,” a range of regulations, benchmarks, and Oncology Solutions’ suggestions are also provided. Clinical Performance Improvement Any proposed change must be implemented carefully. The Performance Improvement Process Template contained in this kit provides a model for successfully managing change. The most important element is to engage those who are involved in the clinical process. Many stake- holders throughout the hospital will be interested in shaping any performance improvement - 1 - initiative. The MAP kit provides samples of how to use the Performance Improvement Process Template, as well as flow charts that pictorially define the process from initial patient contact, to suspicious findings, to diagnosis. Financial Processes The Financial Resource Tools section of this Resource Kit can help hospitals and health systems strengthen the finances of their breast health centers. The financial picture is often bleak for breast health centers. Even as breast centers focus on the clinical aspects of care, negative finan- cial returns threaten the ability to continue providing care. By collaborating with the finance team, outpatient registration personnel, and others in the hospital, managers, physicians, and technologists can enhance the financial performance of their breast health centers. The first step is to understand the current situation. It is important to work with the hospital’s finance team to determine how charges are created, how often are they updated, and who is responsible for researching coding and related billing changes. From the time the patient first registers into the system, there is opportunity for errors that can affect the entire process. Implementation of a clearly defined, accountable process is critical to a financially viable program. This kit provides encounter forms covering services and codes. Charge capture and appropriate coding are two areas of opportunity that are often missed in a breast center. This MAP kit includes Common Breast Cancer Screening, Detection, and Treatment Coding Guidelines, which allow the team to review the Correct Coding Initiative for these situations. Incorrect coding is a recur- ring issue that can substantially affect a breast health center’s financial standing. The Resource Kit also includes fee schedules that detail the unadjusted Medicare fee and the 50th, 75th, and 90th percentiles. For example, the amount listed in the 50th percentile column repre- sents the 50th percentile of usual, customary, and reasonable fees for the specific service or pro- cedure. The 50th percentile is that point where 50% of fees for a given procedure are at or below the amount listed and 50% are higher than the amount listed. These fee schedules allow the health care team to compare the facility’s performance with others throughout the nation. Service and Patient Satisfaction The patient satisfaction surveys included in this kit can be used to foster change. Whether work- ing with patients or with the physicians who refer patients, understanding patient satisfaction can provide a clearer direction for identifying issues, determining solutions, and implementing action plans. As consumers continue to be empowered to make decisions about where to go and where to stay for health care, satisfaction surveys will continue to grow in importance. Positive Change My staff and I were extremely pleased and fortunate to have the opportunity to be a small part of this project. There are those rare cases as a consultant when you absolutely know you have had the opportunity to influence positive change in the ongoing struggle against cancer. This has been one of those times for Oncology Solutions. Rhonda Mealor is a Principal of Oncology Solutions, LLC, with over 17 years experience in oncology consulting. She has assisted
Load more

Recommended publications
  • Future of Breast Elastography
    Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
    [Show full text]
  • Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
    Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
    [Show full text]
  • Breast Ultrasound Accreditation Program Requirements
    Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Screening Automated Whole Breast Ultrasound
    Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Stanford now offers screening automated whole breast ultrasound (SAWBU) at our Stanford Medicine Cancer Center Palo Alto location. This is an optional test that can be used as a supplement to screening mammography in women with mammographically dense breasts. It can find cancers that cannot be seen on mammograms due to overlap with dense breast tissue. Stanford uses automated whole breast technique, a new method developed for accuracy and efficiency. Who is a candidate for SAWBU What will happen during the How is SAWBU exam is examination? SAWBU examination? different? This is an optional test to supplement You will lie on your back, and gel will Screening automated screening mammography in women be applied to your breast. whole breast ultrasound who: uses sound waves (no radi- A large ultrasound handpiece will be • Undergo routine screening with ation) to create 3D pictures placed on the breast, and the system mammography. of the breast tissue, using will automatically take a “sweep” • Have no current signs or a new automated method that obtains ultrasound images of symptoms of breast cancer. developed for accuracy and the tissue from top to bottom. The • Have mammographically dense efficiency. handpiece will be repositioned to take (heterogeneously or extremely other “sweeps” to include all of the It can find cancers that dense) breasts. breast tissue. cannot be seen on mam- • Are not at “high risk" undergoing mograms alone due to supplemental screening with An exam of both breasts takes less overlap with dense breast breast MRI. Screening ultra- than 20 minutes to obtain.
    [Show full text]
  • Evaluation of the Quantitative Accuracy of a Commercially-Available Positron Emission Mammography Scanner
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER Adam Springer Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Diagnosis Commons, Equipment and Supplies Commons, and the Other Medical Sciences Commons Recommended Citation Springer, Adam, "EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 64. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/64 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY- AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER
    [Show full text]
  • What You Should Know About Breast Cancer Screening
    Cancer AnswerLineTM WHAT YOU SHOULD KNOW ABOUT BREAST CANCER SCREENING Women should speak to their health care provider about their risk of breast cancer and whether a screening test is right for them, as well as to review the risks and benefits of screening. The purpose of screening is to find disease early; THE AMERICAN CANCER SOCIETY’S ideally before symptoms appear. Almost all diseases, RECOMMENDATIONS: including cancer, are easier to treat in an earlier • Women between 40 and 44 have the option to stage as opposed to an advanced stage. start screening with a mammogram every year. Women 45 to 54 should get mammograms every While experts may have different opinions regarding • year. when to begin mammography screening and at what frequency, all major U.S. organizations, • Women 55 and older can switch to a mammogram including the American Cancer Society, the every other year, or they can choose to continue National Comprehensive Cancer Network and the yearly mammograms. Screening should continue U.S. Preventive Services Task Force continue to as long as a woman is in good health and is recommend regular screening mammography to expected to live 10 more years or longer. reduce breast cancer mortality. Breast cancer • All women should understand what to expect mortality rates have continued to decrease in the when getting a mammogram for breast cancer United States due to advances in screening and screening—what the test can and cannot do. treatment over the last 20 years. These recommendations apply to asymptomatic Breast cancer screening is broken down into women aged 40 years or older who do not have different classifications based the patient’s age, level preexisting breast cancer or a previously diagnosed of risk (how likely they are to get breast cancer), and high-risk breast lesion and who are not at high risk strength of the recommendation.
    [Show full text]
  • Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound)
    Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound) Background interpreting physician, referring physician/Health Care Provider (HCP), and patient.6 Specifically, the MQSA encourages education More than one-half of women younger than 50 years old and and outreach to patients from medical/scientific organizations, approximately one-third of women 50 years and older have industry, and interpreting physicians. In addition, outreach to dense breasts in the US.1 Higher breast density is associated referring physicians is encouraged from professional organizations with decreased mammographic sensitivity and specificity and and Continuing Medical Education (CME) providers.6 increased breast cancer risk.2 Due to the shortcomings of mammography in this population of women, an individualized Despite widely available options for additional screening and multimodal screening approach is recommended to improve the legislation mandating density inform, uptake and adoption of early detection of breast cancer. No clinical guidelines explicitly supplemental screening has lagged. In addition to knowledge recommend use of supplemental breast cancer screening on gaps, one study identified reimbursement uncertainties (e.g. women with dense breasts,3 but as of March 2018, 33 states have billing, coding and coverage) as a key factor for slow uptake. In enacted legislation requiring that breast density, in addition to 2015, the CPT® codebook was updated to include two new codes mammography results, be reported to women undergoing such for breast ultrasound, CPT 76641 and 76642, for complete and procedures; additional states have introduced or are currently limited exams, respectively.7 These codes replaced CPT 76645. working on legislation.4 Most states require specific density The new and old codes alike do not differentiate the technology inform language distinguishing dense (i.e., BI-RADS® C and D) used to perform an exam (handheld vs.
    [Show full text]
  • Breast Imaging Faqs
    Breast Imaging Frequently Asked Questions Update 2021 The following Q&As address Medicare guidelines on the reporting of breast imaging procedures. Private payer guidelines may vary from Medicare guidelines and from payer to payer; therefore, please be sure to check with your private payers on their specific breast imaging guidelines. Q: What differentiates a diagnostic from a screening mammography procedure? Medicare’s definitions of screening and diagnostic mammography, as noted in the Centers for Medicare and Medicaid’s (CMS’) National Coverage Determination database, and the American College of Radiology’s (ACR’s) definitions, as stated in the ACR Practice Parameter of Screening and Diagnostic Mammography, are provided as a means of differentiating diagnostic from screening mammography procedures. Although Medicare’s definitions are consistent with those from the ACR, the ACR's definitions of screening and diagnostic mammography offer additional insight into what may be included in these procedures. Please go to the CMS and ACR Web site links noted below for more in- depth information about these studies. Medicare Definitions (per the CMS National Coverage Determination for Mammograms 220.4) “A diagnostic mammogram is a radiologic procedure furnished to a man or woman with signs and symptoms of breast disease, or a personal history of breast cancer, or a personal history of biopsy - proven benign breast disease, and includes a physician's interpretation of the results of the procedure.” “A screening mammogram is a radiologic procedure furnished to a woman without signs or symptoms of breast disease, for the purpose of early detection of breast cancer, and includes a physician’s interpretation of the results of the procedure.
    [Show full text]
  • Society of Breast Imaging Statement on Breast Imaging During the COVID-19 Pandemic
    Society of Breast Imaging Statement on Breast Imaging during the COVID-19 Pandemic The Society of Breast Imaging’s core purpose is “to save lives and minimize the impact of breast cancer.” To fulfill that purpose, the SBI strongly advocates for routine annual screening mammography for all women starting at age 40 because the data clearly show this is the best approach to minimizing the mortality due to breast cancer. However, the outbreak of a disease due to a novel strain of coronavirus, COVID-19, raises the difficult question of whether we can provide appropriate screening while also minimizing the impact of this pandemic to our communities. Many of our members have voiced concern that providing routine care for asymptomatic women who may be unknowing carriers of COVID-19 places others at risk. Women seeking ongoing care for breast cancer may be immunocompromised and therefore at increased risk of contracting COVID-19 and developing a severe form of the disease. Others at potential risk include otherwise healthy patients who share waiting areas, restrooms, elevators, and handrails with those unknowingly carrying the disease. Our breast imaging technologists are also at risk, particularly given the very close person-to-person contact required to adequately position patients for high-quality imaging. Finally, maintaining full patient schedules places physicians at risk of contracting the illness. Once exposed or infected, these radiologists may not be available to care for women with more urgent breast imaging needs. SBI recommends that individual facilities delay screening breast imaging exams for several weeks or a few months. Furthermore, diagnostic studies on women without a clinically concerning symptom, such as patients with six month follow-up, should also be delayed.
    [Show full text]
  • ACR Practice Parameter for the Performance of Whole-Breast
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. 2019 (Resolution 34)* ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF WHOLE- BREAST ULTRASOUND FOR SCREENING AND STAGING PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • Breast Imaging Faqs
    Breast Imaging FAQs WHAT IS A SCREENING MAMMOGRAM? A screening mammogram uses low dose digital x-rays of the breast to check for breast cancer in patients with no signs or symptoms of the disease (asymptomatic). Screening mammograms create 2-dimensional (2D) images of the breast tissue that make it possible to detect findings that may be too small to be felt allowing for the early detection and treatment of breast cancer. WHAT IS SCREENING BREAST TOMOSYNTHESIS OR 3D MAMMOGRAPHY? Screening breast tomosynthesis, also referred to as 3D mammography, is added to all standard screening mammograms. Screening tomosynthesis uses a low dose x-ray machine that sweeps over the breast, taking multiple images from different angles; a computer combines these images to create a 3D picture of the breast. The 3D images used in combination with the 2D images have the benefit of helping to improve cancer detection as compared to standard digital mammography alone. Additional imaging obtained with breast tomosynthesis may also help reduce the need for additional testing. WHO SHOULD GET A SCREENING MAMMOGRAM? Current American College of Radiology Guidelines recommend screening mammograms, and a clinical breast examination every year beginning at age 40. Screening mammography is indicated for patients who are not experiencing any symptoms or breast problems (asymptomatic). Talk to your doctor to find out if a screening mammography is right for you. WHAT TO EXPECT DURING THE EXAM? During the exam each breast will be compressed for about 7 to 10 seconds by the digital mammography unit for each view required. Compression is important as it allows for a more detailed view of the breast.
    [Show full text]